Profile
RNXT VRTX ALNY REGN ARGX SGEN
Company Name RenovoRx, Inc. Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $40.68M $100.41B $60.32B $58.82B $48.74B $43.15B
Employees 0.01K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO Shaun R. Bagai Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
RNXT VRTX ALNY REGN ARGX SGEN
Quant Rating Score 2 3 1 4 3 3
Quant Rating Sell Neutral Strong Sell Buy Neutral Neutral
Trading
RNXT VRTX ALNY REGN ARGX SGEN
Last Close $1.11 $407.79 $460.155 $564.63 $796.92 $228.74
High 52 $1.54 $516.74 $482.13 $1016.53 $804.9 $228.74
Low 52 $0.77 $366.54 $224.58 $482.92 $532.27 $228.74
Price vs. 52 Week High -27.92 % -21.08 % -4.56 % -44.46 % -0.99 % 0 %
Price vs. 52 Week Low 44.16 % 11.25 % 104.9 % 16.92 % 49.72 % 0 %
Total Return
RNXT VRTX ALNY REGN ARGX SGEN
1 Month Return -13.28 % 3.36 % -1.23 % 0.83 % 5.36 % 0 %
3 Month Return -13.62 % -13.02 % 46.11 % -0.55 % 42.25 % 0 %
6 Month Return 43.78 % -15.78 % 93.53 % 1.89 % 37.18 % 0 %
9 Month Return -17.78 % -1.35 % 78.17 % -21.24 % 18.87 % 0 %
YTD Return -13.95 % 1.26 % 95.55 % -20.73 % 29.58 % 0 %
1 Year Return 13.27 % -15.35 % 61.84 % -44.41 % 48.49 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
RNXT VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.47 % - -
Dividend Paid and Capex Coverage Ration (TTM) -736.21 % 11.09 % -0.43 % 4.37 % 65.28 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Profitability
RNXT VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM 62.84 % 86.11 % 83.64 % 81.98 % 65.82 % 79.1 %
Return on Assets TTM -78.16 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM -120.68 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM -93.06 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 100 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 94.81 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM -1699.09 % 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM -3964.23 % 251.83 % -1.2 % 175.35 % 932.29 % -1043.73 %
Receivables Turnover TTM 1.82 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM 0.37 3.59 3.93 3.54 0.9 1.97
Inventory Turnover TTM - 1.06 5.62 0.8 2.26 0.96
Fixed Asset Turnover TTM 266.94 % 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM 4.85 % 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -0.28 14.98 -0.12 45.13 5.67 -2.46
Free Cash Flow Per Share TTM -0.28 13.63 -0.4 36.58 5.58 -2.88
Cash Per Share TTM 33.67 % 2486.48 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM -1556.95 % 33.68 % -0.63 % 33.37 % 17.54 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.14 % 90.99 % 335.21 % 81.05 % 98.47 % 117.04 %
Cash Flow Coverage Ratios TTM -3964.23 % 251.83 % -1.2 % 175.35 % 932.29 % -1043.73 %
Price To Free Cash Flows Ratio TTM -3.94 28.69 -1157.98 15.3 123.13 -81.26
Price To Operating Cash Flows Ratio TTM -3.94 26.14 -3840.08 12.51 140.63 -93.1
Price Cash Flow Ratio TTM -3.94 26.14 -3840.08 12.51 140.63 -93.1
Income Statement (TTM)
RNXT VRTX ALNY REGN ARGX SGEN
Revenue $0B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $0B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 100% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $-0.01B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.01B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -0.37 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
RNXT VRTX ALNY REGN ARGX SGEN
Long Term Debt $0B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $0B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $0.01B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
RNXT VRTX ALNY REGN ARGX SGEN
Net Income $-0.01B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $0B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $-0B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 36.44
AARD Aardvark Therapeutics, Inc. Common Stock 14.64
ABCL AbCellera Biologics Inc. 5.6799
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.4
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.125
ABPWW 0.0288
ABSI Absci Corporation 3.655
ABUS Arbutus Biopharma Corporation 4.28
ABVC ABVC BioPharma, Inc. 2.93
ABVX Abivax SA American Depositary Shares 95.69
ACAD ACADIA Pharmaceuticals Inc. 20.06
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.9889
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 3.1
ACIU AC Immune SA 3.52
ETFs With Exposure to RNXT
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00005 326.892
VXF Vanguard Extended Market Index Fund 0.00036 209.655
IWC iShares Micro-Cap ETF 0.00269 153.98
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00028 51.93
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00028 51.92
VBINX Vanguard Balanced Index Fund Investor Shares 0.00028 51.93
VTSAX Vanguard Total Stock Market Index Fund 0.00005 156.59
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00036 155.49
VITSX Vanguard Total Stock Market Index Fund 0.00005 156.62
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000244559 15.86
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00036 155.5
VTS.AX Vanguard US Total Market Shares Index ETF 0.00005 499.58
VEMPX Vanguard Extended Market Index InstlPlus 0.00036 383.72
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00005 293.8
Unlock